gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cerebrovascular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doerfler, A; Engelhorn, T; Essig, M; Hoelter, P; Kloska, S; Knott, MFX; Lang, S; Schmidt, M; Weibart, M | 1 |
| Haller, S; Meckel, S; Mekle, R; Radue, EW; Scheffler, K; Taschner, C; Wetzel, SG | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cerebrovascular Disorders
| Article | Year |
|---|---|
Prospective intraindividual comparison of gadoterate and gadobutrol for cervical and intracranial contrast-enhanced magnetic resonance angiography.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Contrast Media; Female; Heterocyclic Compounds; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Neuroimaging; Organometallic Compounds; Prospective Studies; Signal-To-Noise Ratio | 2017 |
Time-resolved 3D contrast-enhanced MRA with GRAPPA on a 1.5-T system for imaging of craniocervical vascular disease: initial experience.
Topics: Adult; Aged; Algorithms; Angiography, Digital Subtraction; Cerebral Angiography; Cerebrovascular Disorders; Contrast Media; Female; Heterocyclic Compounds; Humans; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds | 2006 |